These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9742773)

  • 1. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
    Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
    Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
    [No Abstract]   [Full Text] [Related]  

  • 2. [The antioxidant protection of the heart by coenzyme Q10 in stable stenocardia of effort].
    Kogan AKh; Syrkin AL; Drinitsina SV; Kokanova IV
    Patol Fiziol Eksp Ter; 1999; (4):16-9. PubMed ID: 10598457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
    Dunaev VV; Kraĭdashenko OV; Berezin AE
    Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intensification in vivo of free radical oxidation of low density lipoproteins in plasma from patients with myocardial ischemia treated by HMG-CoA-reductase pravastatin and suppression of lipid peroxidation by ubiquinone Q10].
    Lankin VZ; Tikhaze AK; Kaminnaia VI; Kaminnyĭ AI; Konovalova GG; Kukharchuk VV
    Biull Eksp Biol Med; 2000 Feb; 129(2):176-9. PubMed ID: 10732240
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of histochrome on the lipid peroxidation indices during the surgical treatment of patients with ischemic heart disease of different functional classes].
    Afanas'ev SA; Lasukova TV; Cherniavskiĭ AM; Vecherskiĭ IuIu; Ponomarenko IV
    Eksp Klin Farmakol; 1999; 62(6):32-4. PubMed ID: 10650524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of coenzyme Q10 injections on exercise tolerance in patients with stable angina pectoris].
    Hiasa Y; Ishida T; Maeda T; Iwano K; Aihara T; Bando M; Nakai Y; Kataoka Y; Mori H
    Kokyu To Junkan; 1983 Apr; 31(4):419-23. PubMed ID: 6867496
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prophylaxis of ischemic heart lesions during chronic heart failure with complex therapy using Q10 coenzyme].
    Shilov AM; Mel'nik MV; Voevodina ES; Osiia AO; Griaznov DA
    Anesteziol Reanimatol; 2011; (2):34-8. PubMed ID: 21692219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The correlations of lipid peroxidation, antioxidant protection and microrheological disorders in the development of IHD].
    Zakirova AN
    Ter Arkh; 1996; 68(9):37-40. PubMed ID: 9005610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of erythrocyte free radical defense system, heart tissue lipid peroxidation, and lipid concentration in streptozotocin-induced diabetic rats under coenzyme Q10 supplementation.
    Al-Thakafy HS; Khoja SM; Al-Marzouki ZM; Zailaie MZ; Al-Marzouki KM
    Saudi Med J; 2004 Dec; 25(12):1824-30. PubMed ID: 15711648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A mathematical analysis of the cardiac activity indices in patients with ischemic heart disease undergoing antianginal pharmacotherapy].
    Arushanian EB; Shamliian TA
    Eksp Klin Farmakol; 1995; 58(1):31-3. PubMed ID: 7787692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indices of lipid peroxidation and atherogenic blood lipoproteins in patients with coronary heart disease receiving antioxidants in addition to basic therapy].
    Reĭzin AB; Tel'nykh IuV
    Klin Med (Mosk); 2005; 83(11):63-4. PubMed ID: 16404943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q10 supplementation and recovery from ischemia in senescent rat myocardium.
    Lönnrot K; Tolvanen JP; Pörsti I; Ahola T; Hervonen A; Alho H
    Life Sci; 1999; 64(5):315-23. PubMed ID: 10072191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
    Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
    Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins.
    Chapidze G; Kapanadze S; Dolidze N; Bachutashvili Z; Latsabidze N
    Georgian Med News; 2005 Jan; (118):20-5. PubMed ID: 15821319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of antioxidants for the correction of coronary risk factors in patients with myocardial ischemia].
    Derbeneva SA; Pogozheva AV; Vasil'ev AV; Akol'zina SE; Lysikova SL
    Vopr Pitan; 2003; 72(4):17-20. PubMed ID: 12968298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme q10: ubiquinone: a potent antioxidant and key energy facilitator for the heart.
    Ross SM
    Holist Nurs Pract; 2007; 21(4):213-4. PubMed ID: 17627201
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood lipids, lipid peroxidation and the effect on them of antianginal preparations in ischemic heart disease patients].
    Serkova VK; Zhebel' VN; Filenko LV; Savitskaia EA
    Eksp Klin Farmakol; 1998; 61(2):75-8. PubMed ID: 9621182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinico-hemodynamic effects of the antioxidant ceruloplasmin in IHD patients].
    Zakirova AN
    Ter Arkh; 1995; 67(4):33-5. PubMed ID: 7784970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial cytoprotection--a clinical reality].
    van Zeller P
    Rev Port Cardiol; 1999 Sep; 18 Suppl 4():IV7-8. PubMed ID: 10555447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.